The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Innate Immune Response Enters Center Stage for Inflammatory Eye Disease

Innate Immune Response Enters Center Stage for Inflammatory Eye Disease

April 25, 2016 • By Lara C. Pullen, PhD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Eye_generic_dreamstime_500x270Whether the infection is obvious or not, ophthalmologists have long suspected that uveitis is triggered by an infectious organism. The process behind the initiation of the disease process, however, has remained obscured by a lack of knowledge about the early inflammatory signals. Now, researchers say a receptor of the innate immune system, the C-type lectin receptor (CLR) mincle, is a critical player in the induction of experimental autoimmune uveoretinitis (EAU). The identification of mincle may be particularly satisfying because mincle expression has previously been implicated in the susceptibility to mycobacterial and fungal infections. The new research, thus, takes the traditional understanding of autoimmune uveitis as a T cell-dependent model of EAU into new territory.

You Might Also Like
  • PAD2 & PAD4 Modulate Immune Response in TLR-7-Dependent Lupus
  • Gut Microbes Activate T Cells Causing Autoimmune Eye Disease
  • Innate Immune Response Predicts Development of Non-Hodgkin’s Lymphoma in Sjögren’s Syndrome
Also By This Author
  • Updated OARSI Guideline for the Non-Surgical Management of Osteoarthritis

Ellen J. Lee, OD, PhD, a research assistant professor of ophthalmology at the Oregon Health and Science University in Portland, and colleagues published the results of their study of the pathogenesis of uveitis in the April 1 issue of the Journal of Immunology. The investigators used knockout mice to tease apart the receptors responsible for the induction of EAU. They began their study by focusing on the caspase-associated recruitment domain adaptor 9 (Card9) protein, which mincle uses for signaling.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The researchers attempted to induce EAU via immunization of wild type and Card9 knockout mice with the interphotoreceptor retinoid binding protein (IRBP). They found the immunized Card9 knockout mice had a diminished proportion of CD4+ cells in the eye when compared with the wild type mice. Specifically, they noted that the lack of EAU in Card9 knockout mice correlated with a decreased ratio of IRBP-specific Th17 vs. IRBP-specific Th1 cells. They explained this finding by documenting that Card9 regulates IRBP-specific production of IL-17A.

Further investigation revealed that, in addition to differences in IRBP-specific T cells, vaccinated Card9 knockout mice had reduced Th1 and Th17 populations in their eyes relative to vaccinated wild type mice. The Card9 knockout mice did, however, have an intact peripheral-associated Th1 response. The authors proposed that this difference was the result of altered T cell trafficking mechanisms. The team concluded from these experiments that Card9 is required for the inflammatory pathway leading to EAU and that Card9 has the ability to influence the development of Th1 vs. Th17 T cell effector responses in EAU.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The researchers next turned their attention to the early/acute phase of the ocular inflammatory response. They found this phase of the response reflected the Card9 transcriptional profile in the retina. Moreover, activation of the proximal CLR mincle appeared to initiate the induction of EAU. The investigators confirmed this with mincle knockout mice, which they found to have decreased severity of EAU relative to wild type mice.

Pages: 1 2 | Single Page

Filed Under: Conditions, Systemic Inflammatory Syndromes Tagged With: Infection, Inflammatory Eye Disease, Uveitis

You Might Also Like:
  • PAD2 & PAD4 Modulate Immune Response in TLR-7-Dependent Lupus
  • Gut Microbes Activate T Cells Causing Autoimmune Eye Disease
  • Innate Immune Response Predicts Development of Non-Hodgkin’s Lymphoma in Sjögren’s Syndrome
  • 2015 ACR/ARHP Annual Meeting: Immune Mediators Can Impact Inflammatory Response

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.